ABBVIE INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.05 USD | +4.64% |
|
+6.18% | +18.75% |
| 28/06 | Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU | MT |
| 28/06 | AbbVie, Genmab Receive Positive European Opinion on Marketing Authorization for Possible Lymphoma Treatment | MT |
454e38bf994c32bd63f3c3db81b5a77.XjapcScW-UfJ8BzCioErk2rllHXdqd1yXWzFQ2qf5Og.b0PvQEB-iAWYu32m1cRv1FjS7TOs-_AaMwCPDBjwkrk2Vd8_dn_UNL6nXQ~52632348147ad889d5bed652cae77ca9
